The company is stopping enrollment in a late-stage study for its lead pipeline candidate.
Compare TNXP Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
Tonix Pharmaceuticals Holding
News & Analysis: Tonix Pharmaceuticals Holding
Lots of irons in the fire could be distracting investors from the most serious problem this company faces right now.
There are some well-known and not-so-well-known names on the list.
They're risky but worth putting on your radar.
This biotech's ambitious development pipeline keeps attracting attention.
It's risky, but it's also intriguing.
The company struck a deal to bolster its COVID-19 pipeline.
These popular Robinhood stocks have two things in common: low share prices and high risk.
There are two main reasons this small-cap biotech stock has gained a lot of attention.
The company reported positive results from a pre-clinical study.